Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
HLVX

HLVX - HilleVax, Inc. Stock Price, Fair Value and News

$2.09 
Market Closed

Price Targets

HLVX Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

HLVX Price Action

Last 7 days

-0.5%

Last 30 days

1.0%

Last 90 days

13.0%

Trailing 12 Months

20.8%

HLVX RSI Chart

HLVX Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

HLVX Valuation

Market Cap

104.8M

Price/Earnings (Trailing)

-1.47

Price/Free Cashflow

-1.76

HLVX Price/Earnings (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

HLVX Fundamentals

HLVX Earnings

Earnings (TTM)

-71.1M

Earnings Growth (Yr)

87.05%

Earnings Growth (Qtr)

13.12%

HLVX Profitability

Return on Equity

-48.1%

Return on Assets

-40.65%

Free Cashflow Yield

-56.79%

HLVX Investor Care

Shares Dilution (1Y)

0.72%

Diluted EPS (TTM)

-1.43

About HilleVax, Inc.

HLVX
HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. The company develops HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus and related illness. The company was formerly known as MokshaCo, Inc. and changed its name to HilleVax, Inc. in February 2021. HilleVax, Inc. was founded in 2019 and is headquartered in Boston, Massachusetts.
 CEO
 WEBSITEhillevax.com
 SECTORHealthcare
 INDUSTRYBiotechnology
 EMPLOYEES62

HilleVax, Inc. Frequently Asked Questions

HLVX is the stock ticker symbol of HilleVax, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

As of Thu Sep 18 2025, market cap of HilleVax, Inc. is 104.79 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check HLVX's fair value in chart for subscribers.

The fair value guage provides a quick view whether HLVX is over valued or under valued. Whether HilleVax, Inc. is cheap or expensive depends on the assumptions which impact HilleVax, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for HLVX.

In the past 10 years, HilleVax, Inc. has provided -0.284 (multiply by 100 for percentage) rate of return.